Over recent years, NEDD4L has been shown to play key roles in the prognosis of tumors such as in prostate cancer3, non-small cell lung cancer (NSCLC)4, cancer of gallbladder5, gastric cancer 6, malignant glioma7, and colorectal cancer8. This evidence concerns the gene NEDD4L and non-small cell lung carcinoma.